CORAL GABLES, Fla., October 28, 2025--(BUSINESS WIRE)--Amerant Bancorp Inc. (NYSE: AMTB) (the "Company" or "Amerant") today reported net income attributable to the Company of $14.8 million in the third quarter of 2025, or $0.35 income per diluted share, compared to net income of $23.0 million, or $0.55 income per diluted share, in the second quarter of 2025.
"While the Company continues to show strong pre-provision net revenue, our results this quarter show higher than expected provision for credit losses as we continued to proactively focus on addressing asset quality over growth this quarter," stated Jerry Plush, Chairman and CEO. "While we anticipate a return to loan growth during the fourth quarter, our primary focus is on reducing non-performing loans. We also intend to resume share buybacks under the existing authorization and implement a new series of expense reductions as key steps toward improving results."
Below are the results for 3Q25 and their comparison to 2Q25:
Total assets were $10.4 billion, up by $75.5 million, or 0.7%, compared to $10.3 billion.
Total gross loans were $6.9 billion, down by $247.4 million, or 3.4%, compared to $7.2 billion.
Cash and cash equivalents were $630.9 million, down by $6.0 million, or 0.9%, compared to $636.8 million.
Investment securities were $2.3 billion, up by $336.8 million, or 17.1%, compared to $2.0 billion.
Total deposits were $8.3 billion, down by $5.6 million, or 0.1%, compared to the prior period, primarily driven by a decrease of $93.7 million in brokered deposits partially offset by customer deposit growth of $88.1 million. Core deposits were $6.2 billion, up by $59.4 million, or 1.0%, compared to $6.1 billion.
Total advances from the Federal Home Loan Bank ("FHLB") were $831.7 million, up by $66.7 million, or 8.7%, compared to $765.0 million.
Net Interest Margin ("NIM") was 3.92%, compared to 3.81%.
Average yield on loans was 6.93%, compared to 6.88%.
Average cost of total deposits was 2.41%, compared to 2.53%.
Loan to deposit ratio was 83.6%, compared to 86.5%.
Asset Quality and Allowance for Credit Losses ("ACL"):
– Total non-performing assets were $139.9 million, up by $42.0 million, or 42.9%, compared to $97.9 million. As of 3Q25, non-performing assets consist of $124.3 million in non-performing loans and $15.6 million in Other Real Estate Owned ("OREO").
– The ACL was $94.9 million, up by $8.4 million, or 9.7%, compared to $86.5 million, primarily from reserve requirements, partially offset by charge-offs in the quarter.
– The Company has provided additional details regarding asset quality in the 3Q25 earnings presentation (https://investor.amerantbank.com).
Assets Under Management and custody ("AUM") totaled $3.17 billion, up by $104.5 million, or 3.4% from $3.07 billion.
Accumulated Other Comprehensive Loss ("AOCL") decreased to $6.9 million, an improvement of $18.5 million, or 72.8%, compared to $25.4 million.
Pre-provision net revenue ("PPNR")(1) was $33.6 million, down by $2.2 million, or 6.3%, compared to PPNR of $35.9 million. Core PPNR(1) was $35.8 million, down by $1.4 million, or 3.7%, compared to $37.1 million. A reconciliation of core PPNR and the impact on key ratios is shown in Exhibit 2 included in this press release.
Net Interest Income ("NII") was $94.2 million, up by $3.7 million, or 4.1%, from $90.5 million.
Provision for credit losses was $14.6 million, up by $8.5 million, or 140.9% compared to $6.1 million.
Non-interest income was $17.3 million, down by $2.5 million, or 12.6% from $19.8 million.
Non-interest expense was $77.8 million, up by $3.4 million, or 4.6% from $74.4 million. Core non-interest expense(1) was $75.9 million, up $2.7 million, or 3.6%, compared to $73.2 million.
The efficiency ratio was 69.84%, compared to 67.48%.
Return on average assets ("ROA") was 0.57%, compared to 0.90%.
Return on average equity ("ROE") was 6.21%, compared to 10.06%.
On October 22, 2025, the Company’s Board of Directors declared a cash dividend of $0.09 per share of common stock. The dividend is payable on November 28, 2025, to shareholders of record on November 14, 2025.
Additional details on the third quarter 2025 results can be found in the Exhibits and Glossary of Terms and Definitions to this earnings release, and the earnings presentation available under the Investor Relations section of the Company’s website at https://investor.amerantbank.com. See Glossary of Terms and Definitions for definitions of financial terms.
1 Non-GAAP measure, see "Non-GAAP Financial Measures" for more information and Exhibit 2 for a reconciliation to GAAP measures. |
Third Quarter 2025 Earnings Conference Call
The Company will hold an earnings conference call on Tuesday, October 28, 2025 at 8:30 a.m. (Eastern Time) to discuss its third quarter 2025 results. The conference call and presentation materials can be accessed via webcast by logging on from the Investor Relations section of the Company’s website at https://investor.amerantbank.com. The online replay will remain available for approximately one month following the call through the above link.
About Amerant Bancorp Inc. (NYSE: AMTB)
Amerant Bancorp Inc. is a bank holding company headquartered in Coral Gables, Florida since 1979. The Company operates through its main subsidiary, Amerant Bank, N.A. (the "Bank"), as well as its other subsidiary Amerant Investments, Inc. The Company provides individuals and businesses with deposit, credit and wealth management services. The Bank, which has operated for over 45 years, is headquartered in Florida and has a network of 22 banking centers – 20 in South Florida and 2 in Tampa, Florida. For more information, visit investor.amerantbank.com.
Cautionary Notice Regarding Forward-Looking Statements
This press release contains "forward-looking statements" including statements with respect to the Company’s objectives, expectations and intentions and other statements that are not historical facts. Examples of forward-looking statements include but are not limited to: our future operating or financial performance, including revenues, expenses, expense savings, income or loss and earnings or loss per share, and other financial items; statements regarding expectations, plans or objectives for future operations, products or services, and our expectations on our investment portfolio repositioning and loan recoveries or reaching positive resolutions on problem loans. All statements other than statements of historical fact are statements that could be forward-looking statements. You can identify these forward-looking statements through our use of words such as "may," "will," "anticipate," "assume," "should," "indicate," "would," "believe," "contemplate," "expect," "estimate," "continue," "plan," "point to," "project," "could," "intend," "target," "goals," "outlooks," "modeled," "dedicated," "create," and other similar words and expressions of the future.
Forward-looking statements, including those relating to our beliefs, plans, objectives, goals, expectations, anticipations, estimates and intentions, involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause the Company’s actual results, performance, achievements, or financial condition to be materially different from future results, performance, achievements, or financial condition expressed or implied by such forward-looking statements. You should not rely on any forward-looking statements as predictions of future events. You should not expect us to update any forward-looking statements, except as required by law. All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by this cautionary notice, together with those risks and uncertainties described in "Risk factors" in our annual report on Form 10-K for the fiscal year ended December 31, 2024 filed on March 5, 2025 ("the 2024 Form 10-K"), and in our other filings with the U.S. Securities and Exchange Commission (the "SEC"), which are available at the SEC’s website www.sec.gov.
Interim Financial Information
Unaudited financial information as of and for interim periods, including the three and nine month periods ended September 30, 2025 and 2024, and the three month periods ended June 30, 2025, March 31, 2025 and December 31 2024 may not reflect our results of operations for our fiscal year ending, or financial condition, as of December 31, 2025, or any other period of time or date.
Non-GAAP Financial Measures
The Company supplements its financial results that are determined in accordance with accounting principles generally accepted in the United States of America ("GAAP") with non-GAAP financial measures, such as "pre-provision net revenue (PPNR)", "core pre-provision net revenue (Core PPNR)", "core noninterest income", "core noninterest expense", "core net income", "core earnings per share (basic and diluted)", "core return on assets (Core ROA)", "core return on equity (Core ROE)", "core efficiency ratio", and "tangible stockholders’ equity (book value) per common share". This supplemental information is not required by, or is not presented in accordance with GAAP. The Company refers to these financial measures and ratios as "non-GAAP financial measures".
We use certain non-GAAP financial measures, including those mentioned above, both to explain our results to shareholders and the investment community and in the internal evaluation and management of our business. Management believes that these supplementary non-GAAP financial measures and the information they provide are useful to investors since these measures permit investors to view our performance using the same tools that our management uses to evaluate our past performance and prospects for future performance. While we believe that these non-GAAP financial measures are useful in evaluating our performance, this information should be considered as supplemental and not as a substitute for or superior to the related financial information prepared in accordance with GAAP. Additionally, these non-GAAP financial measures may differ from similar measures presented by other companies.
Exhibit 2 reconciles these non-GAAP financial measures to GAAP reported results.
Exhibit 1- Selected Financial Information | ||||||||||||||
The following table sets forth selected financial information derived from our interim unaudited and annual audited consolidated financial statements. | ||||||||||||||
(in thousands) | September 30, | June 30, | March 31, | December 31, | September 30, | |||||||||
Consolidated Balance Sheets | (audited) | |||||||||||||
Total assets | $ | 10,410,199 | $ | 10,334,678 | $ | 10,169,688 | $ | 9,901,734 | $ | 10,353,127 | ||||
Total investments | 2,307,701 | 1,970,888 | 1,761,678 | 1,497,925 | 1,542,544 | |||||||||
Total gross loans (1)(2) | 6,941,792 | 7,189,196 | 7,219,162 | 7,271,322 | 7,561,963 | |||||||||
Allowance for credit losses | 94,918 | 86,519 | 98,266 | 84,963 | 79,890 | |||||||||
Total deposits | 8,300,969 | 8,306,544 | 8,154,978 | 7,854,595 | 8,110,944 | |||||||||
Core deposits (1) | 6,203,038 | 6,143,625 | 5,993,055 | 5,620,150 | 5,707,366 | |||||||||
Advances from the Federal Home Loan Bank | 831,699 | 765,000 | 715,000 | 745,000 | 915,000 | |||||||||
Senior notes (3) | — | — | 59,922 | 59,843 | 59,764 | |||||||||
Subordinated notes | 29,752 | 29,710 | 29,667 | 29,624 | 29,582 | |||||||||
Junior subordinated debentures | 64,178 | 64,178 | 64,178 | 64,178 | 64,178 | |||||||||
Stockholders' equity (4)(5)(6) | 944,940 | 924,286 | 906,263 | 890,467 | 902,888 | |||||||||
Assets under management and custody (1) | 3,169,514 | 3,065,020 | 2,932,602 | 2,890,048 | 2,550,541 | |||||||||
Three Months Ended | |||||||||||||||||||
(in thousands, except percentages, share data and per share amounts) | September 30, | June 30, | March 31, | December 31, | September 30, | ||||||||||||||
Consolidated Results of Operations | |||||||||||||||||||
Net interest income | $ | 94,152 | $ | 90,479 | $ | 85,904 | $ | 87,635 | $ | 80,999 | |||||||||
Provision for credit losses (7) | 14,600 | 6,060 | 18,446 | 9,910 | 19,000 | ||||||||||||||
Noninterest income (loss) | 17,291 | 19,778 | 19,525 | 23,684 | (47,683 | ) | |||||||||||||
Noninterest expense | 77,835 | 74,400 | 71,554 | 83,386 | 76,208 | ||||||||||||||
Net income (loss) attributable to Amerant Bancorp Inc. | 14,756 | 23,002 | 11,958 | 16,881 | (48,164 | ) | |||||||||||||
Effective income tax rate | 22.37 | % | 22.80 | % | 22.50 | % | 6.34 | % | 22.18 | % | |||||||||
Common Share Data | |||||||||||||||||||
Stockholders' book value per common share | $ | 22.90 | $ | 22.14 | $ | 21.60 | $ | 21.14 | $ | 21.44 | |||||||||
Tangible stockholders' equity (book value) per common share (8) | $ | 22.32 | $ | 21.56 | $ | 21.03 | $ | 20.56 | $ | 20.87 | |||||||||
Basic earnings (loss) per common share | $ | 0.35 | $ | 0.55 | $ | 0.28 | $ | 0.40 | $ | (1.43 | ) | ||||||||
Diluted earnings (loss) per common share (9) | $ | 0.35 | $ | 0.55 | $ | 0.28 | $ | 0.40 | $ | (1.43 | ) | ||||||||
Basic weighted average shares outstanding | 41,590,201 | 41,805,550 | 42,015,507 | 42,069,098 | 33,784,999 | ||||||||||||||
Diluted weighted average shares outstanding (9) | 41,774,101 | 41,873,551 | 42,186,759 | 42,273,778 | 33,784,999 | ||||||||||||||
Cash dividend declared per common share (5) | $ | 0.09 | $ | 0.09 | $ | 0.09 | $ | 0.09 | $ | 0.09 | |||||||||
Three Months Ended | |||||||||
September 30, | June 30, | March 31, | December 31, | September 30, | |||||
Other Financial and Operating Data (10) | |||||||||
Profitability Indicators (%) | |||||||||
Net interest income / Average total interest earning assets (NIM) (1) | 3.92 % | 3.81 % | 3.75 % | 3.75 % | 3.49 % | ||||
Net income (loss)/ Average total assets (ROA)(1) | 0.57 % | 0.90 % | 0.48 % | 0.67 % | (1.92) % | ||||
Net income (loss)/ Average stockholders' equity (ROE) (1) | 6.21 % | 10.06 % | 5.32 % | 7.38 % | (24.98) % | ||||
Noninterest income (loss) / Total revenue (1) | 15.52 % | 17.94 % | 18.52 % | 21.28 % | (143.12) % | ||||
Capital Indicators (%) | |||||||||
Total capital ratio (1) | 13.90 % | 13.49 % | 13.45 % | 13.43 % | 12.72 % | ||||
Tier 1 capital ratio (1) | 12.28 % | 11.97 % | 11.84 % | 11.95 % | 11.36 % | ||||
Tier 1 leverage ratio (1) | 9.73 % | 9.69 % | 9.73 % | 9.66 % | 9.56 % | ||||
Common equity tier 1 capital ratio (CET1) (1) | 11.54 % | 11.24 % | 11.11 % | 11.21 % | 10.65 % | ||||
Tangible common equity ratio (1)(8) | 8.87 % | 8.73 % | 8.69 % | 8.77 % | 8.51 % | ||||
Liquidity Ratios (%) | |||||||||
Loans to Deposits (1) | 83.63 % | 86.55 % | 88.52 % | 92.57 % | 93.23 % | ||||
Asset Quality Indicators (%) | |||||||||
Non-performing assets / Total assets (1) | 1.34 % | 0.95 % | 1.38 % | 1.23 % | 1.25 % | ||||
Non-performing loans / Total gross loans (1) | 1.79 % | 1.15 % | 1.71 % | 1.43 % | 1.52 % | ||||
Allowance for credit losses / Total non-performing loans | 76.37 % | 104.89 % | 79.75 % | 81.62 % | 69.51 % | ||||
Allowance for credit losses / Total loans held for investment | 1.37 % | 1.20 % | 1.37 % | 1.18 % | 1.15 % | ||||
Net charge-offs / Average total loans held for investment (1)(11) | 0.39 % | 0.86 % | 0.22 % | 0.26 % | 1.90 % | ||||
Efficiency Indicators (% except FTE) | |||||||||
Noninterest expense / Average total assets | 3.01 % | 2.91 % | 2.89 % | 3.29 % | 3.04 % | ||||
Salaries and employee benefits / Average total assets | 1.36 % | 1.41 % | 1.35 % | 1.39 % | 1.39 % | ||||
Other operating expenses/ Average total assets (1) | 1.66 % | 1.50 % | 1.54 % | 1.90 % | 1.64 % | ||||
Efficiency ratio (1) | 69.84 % | 67.48 % | 67.87 % | 74.91 % | 228.74 % | ||||
Full-Time-Equivalent Employees (FTEs) (12) | 704 | 692 | 726 | 698 | 735 | ||||
Three Months Ended | |||||||||||||||||||
(in thousands, except percentages and per share amounts) | September 30, | June 30, | March 31, | December 31, | September 30, | ||||||||||||||
Core Selected Consolidated Results of Operations and Other Data (8) | |||||||||||||||||||
Pre-provision net revenue (loss) (PPNR) | $ | 33,608 | $ | 35,857 | $ | 33,875 | $ | 27,933 | $ | (42,892 | ) | ||||||||
Core pre-provision net revenue (Core PPNR) | $ | 35,765 | $ | 37,122 | $ | 31,546 | $ | 37,217 | $ | 31,264 | |||||||||
Core net income | $ | 16,425 | $ | 23,984 | $ | 10,153 | $ | 21,160 | $ | 9,249 | |||||||||
Core basic earnings per common share | 0.39 | 0.57 | 0.24 | 0.50 | 0.27 | ||||||||||||||
Core earnings per diluted common share (9) | 0.39 | 0.57 | 0.24 | 0.50 | 0.27 | ||||||||||||||
Core net income / Average total assets (Core ROA) (1) | 0.64 | % | 0.94 | % | 0.41 | % | 0.83 | % | 0.37 | % | |||||||||
Core net income / Average stockholders' equity (Core ROE) (1) | 6.91 | % | 10.49 | % | 4.52 | % | 9.25 | % | 4.80 | % | |||||||||
Core efficiency ratio (1) | 67.96 | % | 66.35 | % | 69.24 | % | 64.71 | % | 69.29 | % | |||||||||
__________________ | ||
(1) | See Glossary of Terms and Definitions for definitions of financial terms. | |
(2) | There were no loans held for sale at September 30, 2025. All other periods include mortgage loans held for sale carried at fair value. Additionally, at March 31, 2025 and September 30, 2024, include loans held for sale carried at the lower of cost or fair value. | |
(3) | On April 01, 2025, the Company redeemed all outstanding Senior Notes. See Note 1 to the Company’s consolidated financial statements in our March 31, 2025 Form 10-Q for more information. | |
(4) | On December 11, 2024, the Company announced that the Board of Directors approved to extend the expiration date of its share repurchase program that was set to expire on December 31, 2024 to December 31, 2025 (the "Repurchase Program"). Subsequently, on May 28, 2025, the Company announced that the Board of Directors approved an increase in the amount available for repurchases of the Company’ shares of Class A common stock under the Repurchase Program to $25 million. In the third quarter of 2025 the Company repurchased an aggregate of 487,657 shares of Class A common stock at a weighted average price of $20.51 per share under the Repurchase Program. The aggregate purchase price for these transactions was approximately $10.0 million which includes transaction costs. For all other periods, see June 30, 2025 Form 10-Q, March 31, 2025 Form 10-Q, December 31, 2024 Form 10-K and September 30, 2024 Form 10-Q. | |
(5) | During the three months ended September 30, 2025, June 30, 2025, March 31, 2025, and December 31, 2024, the Company’s Board of Directors declared cash dividends of $0.09 per share of the Company’s common stock and paid an aggregate amount of $3.8 million per quarter in connection with these dividends. The dividend declared in the third quarter of 2025 was paid on August 29, 2025 to shareholders of record at the close of business on August 15, 2025. See December 31, 2024 Form 10-K for more information on dividend payments during the previous quarters. | |
(6) | On September 27, 2024, the Company completed a public offering of 8,684,210 shares of its Class A voting common stock, at a price to the public of $19.00 per share. | |
(7) | In all periods shown, includes reserves on loans and contingent loans. In the third, second and first quarter of 2025, and the fourth and third quarters of 2024, includes $15.3 million, $3.6 million, $17.2 million, $9.7 million and $17.9 million of provision for credit losses on loans. In the third quarter of 2025, includes a reversal of the provision for unfunded commitments (contingencies) of $0.7 million. The provision for unfunded commitments (contingencies) in the second and first quarters of 2025 and the fourth and third quarters of 2024, were $2.5 million, $1.3 million, $0.2 million and $1.1 million, respectively. | |
(8) | This presentation contains adjusted financial information determined by methods other than GAAP. This adjusted financial information is reconciled to GAAP in Exhibit 2 - Non-GAAP Financial Measures Reconciliation. | |
(9) | See 2024 Form 10-K for more information on potential dilutive instruments and its impact on diluted earnings per share computation. | |
(10) | Operating data for the periods presented have been annualized. | |
(11) | See the Company’s June 30, 2025 and March 31, 2025 Form 10-Q, as well as, the 2024 Form 10-K for more details on charge-offs for all previous periods. | |
(12) | As of September 30, 2025, June 30, 2025, March 31, 2025, December 31, 2024, and September 30, 2024, includes 5, 35, 77, 80, and 81 FTEs for Amerant Mortgage, respectively. | |
Exhibit 2- Non-GAAP Financial Measures Reconciliation | |||||||||||||||||||
The following table sets forth selected financial information derived from the Company’s interim unaudited and annual audited consolidated financial statements, adjusted for the effect of non-core banking activities such as the sale of loans and securities and other repossessed assets, the Amerant Mortgage downsizing, the Houston Transaction, the valuation of securities, derivatives, loans held for sale and other real estate owned and repossessed assets, the early repayment of FHLB advances, and other non-routine actions intended to improve customer service and operating performance. The Company believes these adjusted numbers are useful for understanding its performance excluding these transactions and events. | |||||||||||||||||||
Three Months Ended, | |||||||||||||||||||
(in thousands) | September 30, | June 30, | March 31, | December 31, | September 30, | ||||||||||||||
Net income (loss) attributable to Amerant Bancorp Inc. | $ | 14,756 | $ | 23,002 | $ | 11,958 | $ | 16,881 | $ | (48,164 | ) | ||||||||
Plus: provision for credit losses (1) | 14,600 | 6,060 | 18,446 | 9,910 | 19,000 | ||||||||||||||
Plus: provision for income tax expense (benefit) | 4,252 | 6,795 | 3,471 | 1,142 | (13,728 | ) | |||||||||||||
Pre-provision net revenue (loss) (PPNR) | 33,608 | 35,857 | 33,875 | 27,933 | (42,892 | ) | |||||||||||||
Plus: non-routine noninterest expense items | 1,977 | 1,192 | 534 | 15,148 | 5,672 | ||||||||||||||
Plus (less): non-routine noninterest income items | 180 | 73 | (2,863 | ) | (5,864 | ) | 68,484 | ||||||||||||
Core pre-provision net revenue (Core PPNR) | $ | 35,765 | $ | 37,122 | $ | 31,546 | $ | 37,217 | $ | 31,264 | |||||||||
Total noninterest income (loss) | $ | 17,291 | $ | 19,778 | $ | 19,525 | $ | 23,684 | $ | (47,683 | ) | ||||||||
(Plus) Less: Non-routine noninterest income (loss) items: | |||||||||||||||||||
Derivatives (losses), net (2) | (1,383 | ) | (1,852 | ) | — | — | — | ||||||||||||
Securities gains (losses), net (3) | 1,203 | 1,779 | 64 | (8,200 | ) | (68,484 | ) | ||||||||||||
Gain on sale of loans (4) | — | — | 2,799 | — | — | ||||||||||||||
Gain on sale of Houston Franchise (5) | — | — | — | 12,636 | — | ||||||||||||||
Gains on early extinguishment of FHLB advances, net | — | — | — | 1,428 | — | ||||||||||||||
Total non-routine noninterest income (loss) items | $ | (180 | ) | $ | (73 | ) | $ | 2,863 | $ | 5,864 | $ | (68,484 | ) | ||||||
Core noninterest income | $ | 17,471 | $ | 19,851 | $ | 16,662 | $ | 17,820 | $ | 20,801 | |||||||||
Total noninterest expense | $ | 77,835 | $ | 74,400 | $ | 71,554 | $ | 83,386 | $ | 76,208 | |||||||||
Less: non-routine noninterest expense items | |||||||||||||||||||
Non-routine noninterest expense items: | |||||||||||||||||||
Losses on loans held for sale carried at the lower of cost or fair value (6) | 881 | — | — | 12,642 | — | ||||||||||||||
Net losses on sale and valuation expense on other real estate owned (7) | 516 | 822 | 534 | — | 5,672 | ||||||||||||||
Amerant Mortgage downsize costs (8) | 580 | 370 | — | — | — | ||||||||||||||
Legal, broker fees and other costs (5) | — | — | — | 2,506 | — | ||||||||||||||
Total non-routine noninterest expense items | $ | 1,977 | $ | 1,192 | $ | 534 | $ | 15,148 | $ | 5,672 | |||||||||
Core noninterest expense | $ | 75,858 | $ | 73,208 | $ | 71,020 | $ | 68,238 | $ | 70,536 | |||||||||
Three Months Ended, | |||||||||||||||||||
(in thousands, except percentages and per share amounts) | September 30, | June 30, | March 31, | December 31, | September 30, | ||||||||||||||
Net income (loss) attributable to Amerant Bancorp Inc. | $ | 14,756 | $ | 23,002 | $ | 11,958 | $ | 16,881 | $ | (48,164 | ) | ||||||||
Plus after-tax non-routine items in noninterest expense: | |||||||||||||||||||
Non-routine items in noninterest expense before income tax effect | 1,977 | 1,192 | 534 | 15,148 | 5,672 | ||||||||||||||
Income tax effect (9) | (445 | ) | (272 | ) | (120 | ) | (3,409 | ) | (1,332 | ) | |||||||||
Total after-tax non-routine items in noninterest expense | 1,532 | 920 | 414 | 11,739 | 4,340 | ||||||||||||||
Plus (less) after-tax non-routine items in noninterest income: | |||||||||||||||||||
Non-routine items in noninterest income (loss) before income tax effect | 180 | 73 | (2,863 | ) | (5,864 | ) | 68,484 | ||||||||||||
Income tax effect (9) | (43 | ) | (11 | ) | 644 | (1,596 | ) | (15,411 | ) | ||||||||||
Total after-tax non-routine items in noninterest income (loss) | 137 | 62 | (2,219 | ) | (7,460 | ) | 53,073 | ||||||||||||
Core net income | $ | 16,425 | $ | 23,984 | $ | 10,153 | $ | 21,160 | $ | 9,249 | |||||||||
Basic earnings (loss) per share | $ | 0.35 | $ | 0.55 | $ | 0.28 | $ | 0.40 | $ | (1.43 | ) | ||||||||
Plus: after tax impact of non-routine items in noninterest expense | 0.04 | 0.02 | 0.01 | 0.28 | 0.13 | ||||||||||||||
(Less) plus: after tax impact of non-routine items in noninterest income (loss) | — | — | (0.05 | ) | (0.18 | ) | 1.57 | ||||||||||||
Total core basic earnings per common share | $ | 0.39 | $ | 0.57 | $ | 0.24 | $ | 0.50 | $ | 0.27 | |||||||||
Diluted earnings (loss) per share (10) | $ | 0.35 | $ | 0.55 | $ | 0.28 | $ | 0.40 | $ | (1.43 | ) | ||||||||
Plus: after tax impact of non-routine items in noninterest expense | 0.04 | 0.02 | 0.01 | 0.28 | 0.13 | ||||||||||||||
(Less) plus: after tax impact of non-routine items in noninterest income (loss) | — | — | (0.05 | ) | (0.18 | ) | 1.57 | ||||||||||||
Total core diluted earnings per common share | $ | 0.39 | $ | 0.57 | $ | 0.24 | $ | 0.50 | $ | 0.27 | |||||||||
Net income (loss) / Average total assets (ROA) | 0.57 | % | 0.90 | % | 0.48 | % | 0.67 | % | (1.92 | )% | |||||||||
Plus: after tax impact of non-routine items in noninterest expense | 0.06 | % | 0.04 | % | 0.02 | % | 0.46 | % | 0.18 | % | |||||||||
(Less) plus: after tax impact of non-routine items in noninterest income (loss) | 0.01 | % | — | % | (0.09 | )% | (0.30 | )% | 2.11 | % | |||||||||
Core net income / Average total assets (Core ROA) | 0.64 | % | 0.94 | % | 0.41 | % | 0.83 | % | 0.37 | % | |||||||||
Net income (loss)/ Average stockholders' equity (ROE) | 6.21 | % | 10.06 | % | 5.32 | % | 7.38 | % | (24.98 | )% | |||||||||
Plus: after tax impact of non-routine items in noninterest expense | 0.64 | % | 0.40 | % | 0.19 | % | 5.13 | % | 2.25 | % | |||||||||
Plus (less) : after tax impact of non-routine items in noninterest income (loss) | 0.06 | % | 0.03 | % | (0.99 | )% | (3.26 | )% | 27.53 | % | |||||||||
Core net income / Average stockholders' equity (Core ROE) | 6.91 | % | 10.49 | % | 4.52 | % | 9.25 | % | 4.80 | % | |||||||||
Efficiency ratio | 69.84 | % | 67.48 | % | 67.87 | % | 74.91 | % | 228.74 | % | |||||||||
(Less) plus: impact of non-routine items in noninterest expense and noninterest income (loss) | (1.88 | )% | (1.13 | )% | 1.37 | % | (10.20 | )% | (159.45 | )% | |||||||||
Core efficiency ratio | 67.96 | % | 66.35 | % | 69.24 | % | 64.71 | % | 69.29 | % | |||||||||
(in thousands, except percentages, share data and per share amounts) | September 30, | June 30, | March 31, | December 31, | September 30, | ||||||||||||||
Stockholders' equity | $ | 944,940 | $ | 924,286 | $ | 906,263 | $ | 890,467 | $ | 902,888 | |||||||||
Less: goodwill and other intangibles (11) | (23,784 | ) | (24,016 | ) | (24,135 | ) | (24,314 | ) | (24,366 | ) | |||||||||
Tangible common stockholders' equity | $ | 921,156 | $ | 900,270 | $ | 882,128 | $ | 866,153 | $ | 878,522 | |||||||||
Total assets | 10,410,199 | 10,334,678 | 10,169,688 | 9,901,734 | 10,353,127 | ||||||||||||||
Less: goodwill and other intangibles (11) | (23,784 | ) | (24,016 | ) | (24,135 | ) | (24,314 | ) | (24,366 | ) | |||||||||
Tangible assets | $ | 10,386,415 | $ | 10,310,662 | $ | 10,145,553 | $ | 9,877,420 | $ | 10,328,761 | |||||||||
Common shares outstanding | 41,265,378 | 41,748,434 | 41,952,590 | 42,127,316 | 42,103,623 | ||||||||||||||
Tangible common equity ratio | 8.87 | % | 8.73 | % | 8.69 | % | 8.77 | % | 8.51 | % | |||||||||
Stockholders' book value per common share | $ | 22.90 | $ | 22.14 | $ | 21.60 | $ | 21.14 | $ | 21.44 | |||||||||
Tangible stockholders' equity book value per common share | $ | 22.32 | $ | 21.56 | $ | 21.03 | $ | 20.56 | $ | 20.87 | |||||||||
__________________ | ||
(1) | Includes provision for credit losses on loans and provision for loan contingencies. See Footnote 7 in Exhibit 1 - Selected Financial Information for more details. | |
(2) | In the three months ended September 30, 2025 and June 30, 2025, includes net unrealized losses in connection with to-be-announced (TBA) mortgage back-securities (MBS) derivative contracts. We enter into these contracts to economically offset changes in market valuation on the trading securities portfolio. | |
(3) | In the third quarter of 2024, the Company executed an investment portfolio repositioning which resulted in a total pre-tax net loss of $68.5 million during the same period. The investment portfolio repositioning was completed in early October 2024 resulting in an additional $8.1 million in losses in the fourth quarter of 2024. | |
(4) | In the three months ended March 31, 2025, includes gain on sale of $3.2 million, related to the sale of a loan that had been charged off in prior periods. | |
(5) | In the three months ended December 31, 2024, amounts shown are in connection with the sale of the Company’s Houston franchise which were disclosed on a Form 8-K on April 17, 2024 (the "Houston Transaction"). | |
(6) | In the three months ended September 30, 2025, includes loss on sale of $0.9 million related to the sale of one Substandard owner occupied loan with an outstanding balance of $30.4 million at the time of sale. In the three months ended December 31, 2024, includes loss on sale of $12.6 million, including transaction costs, related to the sale of a portfolio of 323 business-purpose, investment property, residential mortgage loans with a balance of approximately $71.4 million. | |
(7) | In the three months ended June 30, 2025, includes a net loss on the sale of two OREO properties of $0.8 million. The three months ended September 30, 2025, March 31, 2025 and September 30, 2024 include an OREO valuation expense of $0.5 million, $0.5 million and $5.7 million, respectively. | |
(8) | In the three months ended September 30, 2025 and June 30, 2025, includes salaries and employee benefit expenses in connection with the Amerant Mortgage downsizing. See First Quarter Earnings Presentation filed on April 24, 2025 for more information. | |
(9) | In the three months ended March 31, 2025, amounts were calculated based upon the effective tax rate for the period of 22.50%. For all of the other periods shown, amounts represent the difference between the prior and current period year-to-date tax effect. | |
(10) | See 2024 Form 10-K for more information on potential dilutive instruments and its impact on diluted earnings per share computation. | |
(11) | At September 30, 2025, June 30, 2025, March 31, 2025, December 31, 2024 and September 30, 2024, other intangible assets primarily consist of naming rights of $1.6 million, $1.6 million, $1.9 million, $2.0 million and $2.1 million , respectively, and mortgage servicing rights ("MSRs") of $1.4 million, $1.5 million, $1.4 million, $1.5 million and $1.4 million, respectively. Other intangible assets are included in other assets in the Company’s consolidated balance sheets. | |
Exhibit 3 - Average Balance Sheet, Interest and Yield/Rate Analysis | ||||||||||||||||||||
The following tables present average balance sheet information, interest income, interest expense and the corresponding average yields earned and rates paid for the periods presented. The average balances for loans include both performing and nonperforming balances. Interest income on loans includes the effects of discount accretion and the amortization of non-refundable loan origination fees, net of direct loan origination costs, accounted for as yield adjustments. Average balances represent the daily average balances for the periods presented. | ||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||
September 30, 2025 | June 30, 2025 | September 30, 2024 | ||||||||||||||||||
(in thousands, except percentages) | Average Balances | Income/ Expense | Yield/ Rates | Average Balances | Income/ Expense | Yield/ Rates | Average Balances | Income/ Expense | Yield/ Rates | |||||||||||
Interest-earning assets: | ||||||||||||||||||||
Loan portfolio, net (1)(2) | $ | 6,946,370 | $ | 121,414 | 6.93 | % | $ | 7,118,087 | $ | 122,166 | 6.88 | % | $ | 7,291,632 | $ | 129,752 | 7.08 | % | ||
Debt securities available for sale (3) (4) | 1,973,763 | 24,146 | 4.85 | % | 1,769,440 | 21,931 | 4.97 | % | 1,313,366 | 14,273 | 4.32 | % | ||||||||
Debt securities held to maturity (5) | — | — | — | % | — | — | — | % | 205,958 | 1,752 | 3.38 | % | ||||||||
Debt securities held for trading | 119,429 | 1,665 | 5.53 | % | 59,331 | 343 | 2.32 | % | — | — | — | % | ||||||||
Equity securities with readily determinable fair value not held for trading | 2,528 | 20 | 3.14 | % | 2,508 | 21 | 3.36 | % | 2,525 | 19 | 2.99 | % | ||||||||
Federal Reserve Bank and FHLB stock | 57,681 | 906 | 6.23 | % | 57,072 | 917 | 6.44 | % | 61,147 | 1,083 | 7.05 | % | ||||||||
Deposits with banks | 413,522 | 4,516 | 4.33 | % | 514,478 | 5,643 | 4.40 | % | 344,469 | 4,670 | 5.39 | % | ||||||||
Other short-term investments | 7,122 | 76 | 4.23 | % | 7,046 | 74 | 4.21 | % | 6,677 | 88 | 5.24 | % | ||||||||
Total interest-earning assets | 9,520,415 | 152,743 | 6.37 | % | 9,527,962 | 151,095 | 6.36 | % | 9,225,774 | 151,637 | 6.54 | % | ||||||||
Total non-interest-earning assets (6) | 723,510 | 728,292 | 760,198 | |||||||||||||||||
Total assets | $ | 10,243,925 | $ | 10,256,254 | $ | 9,985,972 | ||||||||||||||
Three Months Ended | |||||||||||||||||||||||
September 30, 2025 | June 30, 2025 | September 30, 2024 | |||||||||||||||||||||
(in thousands, except percentages) | Average Balances | Income/ Expense | Yield/ Rates | Average Balances | Income/ Expense | Yield/ Rates | Average Balances | Income/ Expense | Yield/ Rates | ||||||||||||||
Interest-bearing liabilities: | |||||||||||||||||||||||
Checking and saving accounts | |||||||||||||||||||||||
Interest bearing DDA | $ | 2,240,617 | $ | 10,892 | 1.93 | % | $ | 2,289,111 | $ | 11,567 | 2.03 | % | $ | 2,294,323 | $ | 15,345 | 2.66 | % | |||||
Money market | 1,918,534 | 17,986 | 3.72 | % | 1,925,029 | 18,012 | 3.75 | % | 1,541,987 | 16,804 | 4.34 | % | |||||||||||
Savings | 236,556 | 22 | 0.04 | % | 236,929 | 18 | 0.03 | % | 247,903 | 26 | 0.04 | % | |||||||||||
Total checking and saving accounts | $ | 4,395,707 | 28,900 | 2.61 | % | 4,451,069 | 29,597 | 2.67 | % | 4,084,213 | 32,175 | 3.13 | % | ||||||||||
Time deposits | 2,084,940 | 20,950 | 3.99 | % | 2,149,861 | 22,285 | 4.16 | % | 2,324,694 | 27,260 | 4.67 | % | |||||||||||
Total deposits | 6,480,647 | 49,850 | 3.05 | % | 6,600,930 | 51,882 | 3.15 | % | 6,408,907 | 59,435 | 3.69 | % | |||||||||||
Securities sold under agreements to repurchase | — | — | — | % | 105 | 1 | 3.82 | % | — | — | — | % | |||||||||||
Advances from the FHLB (7) | 726,520 | 7,316 | 4.00 | % | 717,260 | 7,230 | 4.04 | % | 863,913 | 8,833 | 4.07 | % | |||||||||||
Senior notes | — | — | — | % | — | 78 | — | % | 59,725 | 942 | 6.27 | % | |||||||||||
Subordinated notes | 29,731 | 362 | 4.83 | % | 29,689 | 361 | 4.88 | % | 29,561 | 361 | 4.86 | % | |||||||||||
Junior subordinated debentures | 64,178 | 1,063 | 6.57 | % | 64,178 | 1,064 | 6.64 | % | 64,178 | 1,067 | 6.61 | % | |||||||||||
Total interest-bearing liabilities | 7,301,076 | 58,591 | 3.18 | % | 7,412,162 | 60,616 | 3.28 | % | 7,426,284 | 70,638 | 3.78 | % | |||||||||||
Non-interest-bearing liabilities: | |||||||||||||||||||||||
Non-interest bearing demand deposits | 1,726,507 | 1,637,173 | 1,491,406 | ||||||||||||||||||||
Accounts payable, accrued liabilities and other liabilities | 273,921 | 289,909 | 301,373 | ||||||||||||||||||||
Total non-interest-bearing liabilities | 2,000,428 | 1,927,082 | 1,792,779 | ||||||||||||||||||||
Total liabilities | 9,301,504 | 9,339,244 | 9,219,063 | ||||||||||||||||||||
Stockholders’ equity | 942,421 | 917,010 | 766,909 | ||||||||||||||||||||
Total liabilities and stockholders' equity | $ | 10,243,925 | $ | 10,256,254 | $ | 9,985,972 | |||||||||||||||||
Excess of average interest-earning assets over average interest-bearing liabilities | $ | 2,219,339 | $ | 2,115,800 | $ | 1,799,490 | |||||||||||||||||
Net interest income | $ | 94,152 | $ | 90,479 | $ | 80,999 | |||||||||||||||||
Net interest rate spread | 3.19 | % | 3.08 | % | 2.76 | % | |||||||||||||||||
Net interest margin (7) | 3.92 | % | 3.81 | % | 3.49 | % | |||||||||||||||||
Cost of total deposits (7) | 2.41 | % | 2.53 | % | 2.99 | % | |||||||||||||||||
Ratio of average interest-earning assets to average interest-bearing liabilities | 130.40 | % | 128.54 | % | 124.23 | % | |||||||||||||||||
Average non-performing loans/ Average total loans | 1.30 | % | 1.35 | % | 1.54 | % | |||||||||||||||||
Nine Months Ended | |||||||||||||||
September 30, 2025 | September 30, 2024 | ||||||||||||||
(in thousands, except percentages) | Average Balances | Income/ Expense | Yield/ Rates | Average Balances | Income/ Expense | Yield/ Rates | |||||||||
Interest-earning assets: | |||||||||||||||
Loan portfolio, net (1)(2) | $ | 7,078,705 | $ | 364,601 | 6.89 | % | $ | 7,102,716 | $ | 376,574 | 7.08 | % | |||
Debt securities available for sale (3) (4) | 1,740,625 | 64,041 | 4.92 | % | 1,273,797 | 41,562 | 4.36 | % | |||||||
Debt securities held to maturity (5) | — | — | — | % | 217,272 | 5,597 | 3.44 | % | |||||||
Debt securities held for trading | 60,075 | 2,008 | 4.47 | % | — | — | — | % | |||||||
Equity securities with readily determinable fair value not held for trading | 2,511 | 60 | 3.19 | % | 2,490 | 87 | 4.67 | % | |||||||
Federal Reserve Bank and FHLB stock | 57,359 | 2,759 | 6.43 | % | 55,352 | 2,922 | 7.05 | % | |||||||
Deposits with banks | 502,191 | 16,560 | 4.41 | % | 377,139 | 15,681 | 5.55 | % | |||||||
Other short-term investments | 6,870 | 217 | 4.22 | % | 6,337 | 248 | 5.22 | % | |||||||
Total interest-earning assets | 9,448,336 | 450,246 | 6.37 | % | 9,035,103 | 442,671 | 6.54 | % | |||||||
Total non-interest-earning assets (6) | 733,305 | 788,240 | |||||||||||||
Total assets | $ | 10,181,641 | $ | 9,823,343 | |||||||||||
Interest-bearing liabilities: | |||||||||||||||
Checking and saving accounts | |||||||||||||||
Interest bearing DDA | $ | 2,221,543 | $ | 32,913 | 1.98 | % | $ | 2,382,548 | $ | 49,860 | 2.80 | % | |||
Money market | 1,884,975 | 52,651 | 3.73 | % | 1,462,034 | 46,611 | 4.26 | % | |||||||
Savings | 237,764 | 62 | 0.03 | % | 254,661 | 79 | 0.04 | % | |||||||
Total checking and saving accounts | 4,344,282 | 85,626 | 2.64 | % | 4,099,243 | 96,550 | 3.15 | % | |||||||
Time deposits | 2,153,720 | 67,093 | 4.17 | % | 2,291,539 | 79,355 | 4.63 | % | |||||||
Total deposits | 6,498,002 | 152,719 | 3.14 | % | 6,390,782 | 175,905 | 3.68 | % | |||||||
Securities sold under agreements to repurchase | 35 | 1 | 3.82 | % | 41 | 2 | 6.52 | % | |||||||
Advances from the FHLB (7) | 722,493 | 21,746 | 4.02 | % | 749,195 | 21,357 | 3.81 | % | |||||||
Senior notes | 19,742 | 1,020 | 6.91 | % | 59,646 | 2,826 | 6.33 | % | |||||||
Subordinated notes | 29,689 | 1,084 | 4.88 | % | 29,519 | 1,083 | 4.90 | % | |||||||
Junior subordinated debentures | 64,178 | 3,141 | 6.54 | % | 64,178 | 3,176 | 6.61 | % | |||||||
Total interest-bearing liabilities | 7,334,139 | 179,711 | 3.28 | % | 7,293,361 | 204,349 | 3.74 | % | |||||||
Non-interest-bearing liabilities: | |||||||||||||||
Non-interest bearing demand deposits | 1,636,816 | 1,459,325 | |||||||||||||
Accounts payable, accrued liabilities and other liabilities | 287,021 | 318,273 | |||||||||||||
Total non-interest-bearing liabilities | 1,923,837 | 1,777,598 | |||||||||||||
Total liabilities | 9,257,976 | 9,070,959 | |||||||||||||
Stockholders’ equity | 923,665 | 752,384 | |||||||||||||
Total liabilities and stockholders' equity | $ | 10,181,641 | $ | 9,823,343 | |||||||||||
Excess of average interest-earning assets over average interest-bearing liabilities | $ | 2,114,197 | $ | 1,741,742 | |||||||||||
Net interest income | $ | 270,535 | $ | 238,322 | |||||||||||
Net interest rate spread | 3.09 | % | 2.80 | % | |||||||||||
Net interest margin (7) | 3.83 | % | 3.52 | % | |||||||||||
Cost of total deposits (7) | 2.51 | % | 2.99 | % | |||||||||||
Ratio of average interest-earning assets to average interest-bearing liabilities | 128.83 | % | 123.88 | % | |||||||||||
Average non-performing loans/ Average total loans | 1.36 | % | 0.93 | % | |||||||||||
(1) | Includes loans held for investment net of the allowance for credit losses, and loans held for sale. The average balance of the allowance for credit losses was $88.1 million, $94.8 million, and $92.1 million in the three months ended September 30, 2025, June 30, 2025 and September 30, 2024, respectively, and $88.8 million and $93.2 million in the nine months ended September 30, 2025 and 2024, respectively. The average balance of total loans held for sale was $8.9 million, $53.6 million and $612.9 million in the three months ended September 30, 2025, June 30, 2025 and September 30, 2024, respectively, and $36.1 million and $352.8 million in the nine months ended September 30, 2025 and 2024, respectively. | |
(2) | Includes average non-performing loans of $91.2 million, $97.6 million and $113.5 million for the three months ended September 30, 2025, June 30, 2025 and September 30, 2024, respectively, and $97.5 million and $66.3 million in the nine months ended September 30, 2025 and 2024, respectively. | |
(3) | Includes the average balance of net unrealized gains and losses in the fair value of debt securities available for sale. The average balance includes average net unrealized losses of $32.7 million, $43.5 million and $89.4 million in the three months ended September 30, 2025, June 30, 2025 and September 30, 2024, respectively, and $41.0 million and $102.2 million in the nine months ended September 30, 2025 and 2024, respectively. | |
(4) | Includes nontaxable securities with average balances of $54.2 million, $53.9 million and $19.9 million for the three months ended September 30, 2025, June 30, 2025 and September 30, 2024, respectively, and $54.6 million and $19.9 million in the nine months ended September 30, 2025 and 2024, respectively. The tax equivalent yield for these nontaxable securities was 4.60%, 4.81%, and 4.33% for the three months ended September 30, 2025, June 30, 2025 and September 30, 2024, respectively, and 4.68% and 4.28% in the nine months ended September 30, 2025 and 2024, respectively. In 2025 and 2024, the tax equivalent yields were calculated assuming a 21% tax rate and dividing the actual yield by 0.79. | |
(5) | We had no average held to maturity balances in the three and nine months ended September 30, 2025, and in the three months ended June 30, 2025. Includes nontaxable securities with average balances of $44.5 million and $47.8 million for the three and nine month periods ended September 30, 2024, respectively. The tax equivalent yield for these nontaxable securities were 4.43% and 4.23% for the three and nine month periods ended September 30, 2024, respectively. In 2024, the tax equivalent yield was calculated assuming a 21% tax rate and dividing the actual yield by 0.79. | |
(6) | Excludes the allowance for credit losses. | |
(7) | See Glossary of Terms and Definitions for definitions of financial terms. |
Exhibit 4 - Noninterest Income | ||||||||||||||||||||||||||||||||
This table shows the amounts of each of the categories of noninterest income for the periods presented. | ||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||
September 30, 2025 | June 30, 2025 | September 30, 2024 | 2025 | 2024 | ||||||||||||||||||||||||||||
(in thousands, except percentages) | Amount | % | Amount | % | Amount | % | Amount | % | Amount | % | ||||||||||||||||||||||
Deposits and service fees | $ | 5,056 | 29.2 | % | $ | 4,968 | 25.1 | % | $ | 5,046 | 10.6 | % | $ | 15,161 | 26.8 | % | $ | 14,652 | 106.4 | % | ||||||||||||
Brokerage, advisory and fiduciary activities | 4,995 | 28.9 | % | 4,993 | 25.2 | % | 4,466 | 9.4 | % | 14,717 | 26.0 | % | 13,331 | 96.8 | % | |||||||||||||||||
Change in cash surrender value of bank owned life insurance ("BOLI")(1) | 2,554 | 14.8 | % | 2,490 | 12.6 | % | 2,332 | 4.9 | % | 7,494 | 13.2 | % | 6,916 | 50.2 | % | |||||||||||||||||
Cards and trade finance servicing fees | 1,321 | 7.6 | % | 1,804 | 9.1 | % | 1,430 | 3.0 | % | 4,517 | 8.0 | % | 3,984 | 28.9 | % | |||||||||||||||||
Gain on early extinguishment of FHLB advances, net | — | — | % | — | — | % | — | — | % | — | — | % | 189 | 1.4 | % | |||||||||||||||||
Securities gains (losses), net (2) | 1,203 | 7.0 | % | 1,779 | 9.0 | % | (68,484 | ) | (143.6 | )% | 3,046 | 5.4 | % | (68,655 | ) | (498.4 | )% | |||||||||||||||
Loan-level derivative income (3) | 2,372 | 13.7 | % | 3,204 | 16.2 | % | 3,515 | 7.4 | % | 7,084 | 12.5 | % | 6,338 | 46.0 | % | |||||||||||||||||
Derivative losses, net (4) | (1,383 | ) | (8.0 | )% | (1,852 | ) | (9.4 | )% | — | — | % | (3,235 | ) | (5.7 | )% | (196 | ) | (1.4 | )% | |||||||||||||
Other noninterest income (5) | 1,173 | 6.8 | % | 2,392 | 12.2 | % | 4,012 | 8.3 | % | 7,810 | 13.8 | % | 9,666 | 70.1 | % | |||||||||||||||||
Total noninterest income (loss) | $ | 17,291 | 100.0 | % | $ | 19,778 | 100.0 | % | $ | (47,683 | ) | (100.0 | )% | $ | 56,594 | 100.0 | % | $ | (13,775 | ) | (100.0 | )% | ||||||||||
__________________ | ||
(1) | Changes in cash surrender value of BOLI are not taxable. | |
(2) | In the three months ended September 30, 2025 and June 30, 2025, and in the nine months ended September 30, 2025, amounts are primarily in connection with gains on market valuation of trading securities. In the three and nine months ended September 30, 2024, includes a total net loss of $68.5 million as a result of the investment portfolio repositioning initiated during the third quarter of 2024. See Exhibit 2- Non-GAAP Financial Measures Reconciliation for more details. | |
(3) | Income from interest rate swaps and other derivative transactions with customers. The Company incurs expenses related to derivative transactions with customers which are included as part of noninterest expenses under loan-level derivative expense. See Exhibit 5 for more details. | |
(4) | In the three and nine months ended September 30, 2025 and in the three months ended June 30, 2025, includes net unrealized losses in connection with TBA MBS derivative contracts. We enter into these contracts to economically offset changes in market valuation on the trading securities portfolio. In all other prior periods, includes net unrealized losses and gains related to uncovered interest rate caps with clients. | |
(5) | Includes mortgage banking loss of $0.4 million in the three months ended September 30, 2025, and mortgage banking income of $0.7 million and $2.8 million in the three months ended June 30, 2025 and September 30, 2024, respectively, and $0.8 million and $5.8 million, in the nine months ended September 30, 2025 and 2024, respectively, primarily consisting of net gains/losses on sale, valuation and derivative transactions associated with mortgage loans held for sale activity, and other smaller sources of income related to the operations of Amerant Mortgage. Other sources of income in the periods shown include net gains/(losses) on sales of loans that are originated for investment, foreign currency exchange transactions with customers and valuation income on the investment balances held in the non-qualified deferred compensation plan. In addition, includes $0.5 million BOLI death benefits received in the nine months ended September 30, 2024. Other noninterest income for the nine months ended September 30, 2025 includes a total of approximately $2.8 million as a Non-routine noninterest income item. See Exhibit 2- Non-GAAP Financial Measures Reconciliation for more details. | |
Exhibit 5 - Noninterest Expense | ||||||||||||||||||||||||
This table shows the amounts of each of the categories of noninterest expense for the periods presented. | ||||||||||||||||||||||||
Three Months Ended | Nine Months Ended September 30, | |||||||||||||||||||||||
September 30, 2025 | June 30, 2025 | September 30, 2024 | 2025 | 2024 | ||||||||||||||||||||
(in thousands, except percentages) | Amount | % | Amount | % | Amount | % | Amount | % | Amount | % | ||||||||||||||
Salaries and employee benefits (1) | $ | 35,094 | 45.1 | % | $ | 36,036 | 48.4 | % | $ | 34,979 | 45.9 | % | $ | 104,477 | 46.7 | % | $ | 101,794 | 47.1 | % | ||||
Professional and other services fees (2) | 15,997 | 20.6 | % | 13,549 | 18.2 | % | 13,711 | 18.0 | % | 44,228 | 19.8 | % | 36,784 | 17.0 | % | |||||||||
Occupancy and equipment (3) | 5,211 | 6.7 | % | 5,491 | 7.4 | % | 5,891 | 7.7 | % | 16,838 | 7.5 | % | 21,408 | 9.9 | % | |||||||||
Telecommunications and data processing | 3,155 | 4.1 | % | 2,929 | 3.9 | % | 2,991 | 3.9 | % | 9,559 | 4.3 | % | 9,256 | 4.3 | % | |||||||||
Depreciation and amortization | 1,487 | 1.9 | % | 1,551 | 2.1 | % | 1,737 | 2.3 | % | 4,626 | 2.1 | % | 4,866 | 2.3 | % | |||||||||
FDIC assessments and insurance | 2,549 | 3.3 | % | 2,896 | 3.9 | % | 2,863 | 3.8 | % | 8,681 | 3.9 | % | 8,643 | 4.0 | % | |||||||||
Losses on loans held for sale carried at the lower of cost or fair value (4) | 881 | 1.1 | % | — | — | % | — | — | % | 881 | 0.4 | % | 1,258 | 0.6 | % | |||||||||
Advertising expenses | 3,987 | 5.1 | % | 4,819 | 6.5 | % | 3,468 | 4.6 | % | 12,441 | 5.6 | % | 10,789 | 5.0 | % | |||||||||
Loan-level derivative expense (5) | 1,834 | 2.4 | % | 1,113 | 1.5 | % | 1,802 | 2.4 | % | 3,307 | 1.5 | % | 2,386 | 1.1 | % | |||||||||
Other real estate owned and repossessed assets expense, net (6) | 215 | 0.3 | % | 601 | 0.8 | % | 5,535 | 7.3 | % | 980 | 0.4 | % | 5,033 | 2.3 | % | |||||||||
Other operating expenses (7) | 7,425 | 9.4 | % | 5,415 | 7.3 | % | 3,231 | 4.1 | % | 17,771 | 7.8 | % | 13,887 | 6.4 | % | |||||||||
Total noninterest expense (8) | $ | 77,835 | 100.0 | % | $ | 74,400 | 100.0 | % | $ | 76,208 | 100.0 | % | $ | 223,789 | 100.0 | % | $ | 216,104 | 100.0 | % | ||||
__________________ | ||
(1) | Includes expenses in connection with the Amerant Mortgage downsizing of $0.6 million, $0.4 million and $1.0 million in the three months ended September 30, 2025 and June 30, 2025 and the nine months ended September 30, 2025, respectively. See Exhibit 2- Non-GAAP Financial Measures Reconciliation for more details. | |
(2) | In the nine month period ended September 30, 2024, includes $0.3 million in legal expenses in connection with the Houston Transaction. Additionally, includes recurring service fees in connection with the engagement of FIS in all periods shown. | |
(3) | In the nine month period ended September 30, 2024, includes fixed assets impairment charge of $3.4 million in connection with the Houston Transaction. | |
(4) | In the three and nine month periods ended September 30, 2025, amounts are in connection with the sale of one loan. In the nine month period ended September 30, 2024, amounts shown are in connection with the Houston Transaction. See Exhibit 2- Non-GAAP Financial Measures Reconciliation for more details. | |
(5) | Includes service fees in connection with our loan-level derivative income generation activities. | |
(6) | Includes OREO valuation expense of $0.5 million and $5.7 million in the three months ended September 30, 2025 and 2024, respectively, and $1.1 million and $5.7 million in the nine months ended September 30, 2025 and 2024, respectively. In addition, includes net loss on the sale of two OREO properties of $0.8 million in each of the three months ended June 30, 2025 and the nine months ended September 30, 2025. See Exhibit 2- Non-GAAP Financial Measures Reconciliation for more details. | |
(7) | Includes earnings credits which are provided to certain commercial depositors in the mortgage banking industry to help offset deposit service charges incurred. These earnings credits were $3.5 million, $2.6 million, and $7.4 million in the three months ended September 30, 2025 and June 30, 2025, and the nine months ended September 30, 2025, respectively. In addition, in the nine months ended September 30, 2024, includes broker fees of $0.3 million in connection with the Houston Transaction. See the Company’s 2024 Form 10K for details on all other components of other non-interest expenses. | |
(8) | Includes $2.1 million, $3.0 million, and $3.9 million in the three months ended September 30, 2025, June 30, 2025 and September 30, 2024, respectively, and $8.3 million and $10.5 million in the nine months ended September 30, 2025 and 2024, respectively, related to Amerant Mortgage, primarily consisting of salaries and employee benefits, mortgage lending costs and professional and other services fees. | |
Exhibit 6 - Consolidated Balance Sheets | |||||||||||||||||||
(in thousands, except share data) | September 30, | June 30, | March 31, | December 31, | September 30, | ||||||||||||||
Assets | (audited) | ||||||||||||||||||
Cash and due from banks | $ | 46,190 | $ | 48,400 | $ | 40,197 | $ | 39,197 | $ | 40,538 | |||||||||
Interest earning deposits with banks | 570,612 | 573,373 | 587,728 | 519,853 | 614,345 | ||||||||||||||
Restricted cash | 6,894 | 7,981 | 13,432 | 24,365 | 10,087 | ||||||||||||||
Other short-term investments | 7,162 | 7,083 | 7,010 | 6,944 | 6,871 | ||||||||||||||
Cash and cash equivalents | 630,858 | 636,837 | 648,367 | 590,359 | 671,841 | ||||||||||||||
Securities | |||||||||||||||||||
Debt securities available for sale, at fair value | 2,122,416 | 1,788,708 | 1,702,111 | 1,437,170 | 1,476,378 | ||||||||||||||
Trading securities (1) | 119,935 | 120,226 | — | — | — | ||||||||||||||
Equity securities with readily determinable fair value not held for trading | 2,542 | 2,525 | 2,523 | 2,477 | 2,562 | ||||||||||||||
Federal Reserve Bank and Federal Home Loan Bank stock | 62,808 | 59,429 | 57,044 | 58,278 | 63,604 | ||||||||||||||
Securities | 2,307,701 | 1,970,888 | 1,761,678 | 1,497,925 | 1,542,544 | ||||||||||||||
Loans held for sale, at the lower of cost or fair value (2) | — | — | 40,597 | — | 553,941 | ||||||||||||||
Mortgage loans held for sale, at fair value | — | 6,073 | 20,728 | 42,911 | 43,851 | ||||||||||||||
Loans held for investment, gross | 6,941,792 | 7,183,123 | 7,157,837 | 7,228,411 | 6,964,171 | ||||||||||||||
Less: Allowance for credit losses | 94,918 | 86,519 | 98,266 | 84,963 | 79,890 | ||||||||||||||
Loans held for investment, net | 6,846,874 | 7,096,604 | 7,059,571 | 7,143,448 | 6,884,281 | ||||||||||||||
Bank owned life insurance | 258,042 | 255,487 | 252,997 | 243,547 | 241,183 | ||||||||||||||
Premises and equipment, net | 30,268 | 31,543 | 31,803 | 31,814 | 32,866 | ||||||||||||||
Deferred tax assets, net | 46,881 | 50,966 | 53,448 | 53,543 | 41,138 | ||||||||||||||
Operating lease right-of-use assets | 102,872 | 102,558 | 104,578 | 100,028 | 100,158 | ||||||||||||||
Goodwill | 19,193 | 19,193 | 19,193 | 19,193 | 19,193 | ||||||||||||||
Accrued interest receivable and other assets (3)(4) | 167,510 | 164,529 | 176,728 | 178,966 | 222,131 | ||||||||||||||
Total assets | $ | 10,410,199 | $ | 10,334,678 | $ | 10,169,688 | $ | 9,901,734 | $ | 10,353,127 | |||||||||
Liabilities and Stockholders' Equity | |||||||||||||||||||
Deposits | |||||||||||||||||||
Demand | |||||||||||||||||||
Noninterest bearing | $ | 1,768,764 | $ | 1,706,580 | $ | 1,665,468 | $ | 1,504,755 | $ | 1,482,061 | |||||||||
Interest bearing | 2,294,310 | 2,281,611 | 2,260,157 | 2,229,467 | 2,389,605 | ||||||||||||||
Savings and money market | 2,139,964 | 2,155,434 | 2,067,430 | 1,885,928 | 1,835,700 | ||||||||||||||
Time | 2,097,931 | 2,162,919 | 2,161,923 | 2,234,445 | 2,403,578 | ||||||||||||||
Total deposits | 8,300,969 | 8,306,544 | 8,154,978 | 7,854,595 | 8,110,944 | ||||||||||||||
Advances from the Federal Home Loan Bank | 831,699 | 765,000 | 715,000 | 745,000 | 915,000 | ||||||||||||||
Senior notes (5) | — | — | 59,922 | 59,843 | 59,764 | ||||||||||||||
Subordinated notes | 29,752 | 29,710 | 29,667 | 29,624 | 29,582 | ||||||||||||||
Junior subordinated debentures held by trust subsidiaries | 64,178 | 64,178 | 64,178 | 64,178 | 64,178 | ||||||||||||||
Operating lease liabilities (6) | 109,726 | 109,226 | 110,999 | 106,071 | 105,875 | ||||||||||||||
Accounts payable, accrued liabilities and other liabilities (7) | 128,935 | 135,734 | 128,681 | 151,956 | 164,896 | ||||||||||||||
Total liabilities | 9,465,259 | 9,410,392 | 9,263,425 | 9,011,267 | 9,450,239 | ||||||||||||||
Stockholders’ equity | |||||||||||||||||||
Class A common stock | 4,125 | 4,173 | 4,195 | 4,214 | 4,210 | ||||||||||||||
Additional paid in capital | 327,205 | 336,021 | 339,038 | 343,828 | 342,508 | ||||||||||||||
Retained earnings | 620,542 | 609,540 | 590,304 | 582,231 | 569,131 | ||||||||||||||
Accumulated other comprehensive loss | (6,932 | ) | (25,448 | ) | (27,274 | ) | (39,806 | ) | (12,961 | ) | |||||||||
Total stockholders' equity | 944,940 | 924,286 | 906,263 | 890,467 | 902,888 | ||||||||||||||
Total liabilities and stockholders' equity | $ | 10,410,199 | $ | 10,334,678 | $ | 10,169,688 | $ | 9,901,734 | $ | 10,353,127 | |||||||||
__________________ | ||
(1) | Beginning in the period ended June 30, 2025, the Company started participating in trading of MBS as part of its investment portfolio strategy. | |
(2) | As of March 31, 2025, loans held for sale consisted of one loan carried at cost for which no valuation allowance was deemed necessary. As of September 30, 2024, includes loans held for sale and a valuation allowance of $1.3 million, in connection with the Houston Transaction. | |
(3) | As of September 30, 2025, June 30, 2025, March 31, 2025, December 31, 2024, and September 30, 2024 , includes derivative assets with a total fair value of $40.8 million, $43.7 million, $42.8 million, $48.0 million and $52.3 million, respectively. | |
(4) | As of September 30, 2024, includes other assets for sale of approximately $21.4 million in connection with the Houston Transaction. | |
(5) | On March 03, 2025, the Company gave notice of its election to redeem all outstanding Senior Notes and they were redeemed on April 01, 2025. See Note 1 to the Company’s consolidated financial statements in our March 31, 2025 Form 10-Q for more information. | |
(6) | Consists of total long-term lease liabilities. Total short-term lease liabilities are included in other liabilities. | |
(7) | As of September 30, 2025, June 30, 2025, March 31, 2025, December 31, 2024, and September 30, 2024, includes derivatives liabilities with a total fair value of $39.9 million, $44.6 million, $42.4 million, $47.6 million and $51.3 million, respectively. | |
Exhibit 7 - Loans | ||||||||||||||
Loans by Type - Held For Investment | ||||||||||||||
The loan portfolio held for investment consists of the following loan classes: | ||||||||||||||
(in thousands) | September 30, | June 30, | March 31, | December 31, | September 30, | |||||||||
Real estate loans | (audited) | |||||||||||||
Commercial real estate | ||||||||||||||
Non-owner occupied | $ | 1,656,180 | $ | 1,770,403 | $ | 1,641,210 | $ | 1,678,473 | $ | 1,688,308 | ||||
Multi-family residential | 361,650 | 371,692 | 400,371 | 336,229 | 351,815 | |||||||||
Land development and construction loans | 544,727 | 543,697 | 499,663 | 483,210 | 421,489 | |||||||||
2,562,557 | 2,685,792 | 2,541,244 | 2,497,912 | 2,461,612 | ||||||||||
Single-family residential | 1,550,724 | 1,542,447 | 1,549,356 | 1,528,080 | 1,499,599 | |||||||||
Owner occupied | 900,596 | 983,090 | 951,311 | 1,007,074 | 1,001,762 | |||||||||
5,013,877 | 5,211,329 | 5,041,911 | 5,033,066 | 4,962,973 | ||||||||||
Commercial loans | 1,519,778 | 1,566,420 | 1,714,583 | 1,751,902 | 1,630,318 | |||||||||
Loans to financial institutions and acceptances | 164,974 | 156,918 | 153,345 | 170,435 | 92,489 | |||||||||
Consumer loans and overdrafts | 243,163 | 248,456 | 247,998 | 273,008 | 278,391 | |||||||||
Total loans | $ | 6,941,792 | $ | 7,183,123 | $ | 7,157,837 | $ | 7,228,411 | $ | 6,964,171 | ||||
Loans by Type - Held For Sale | ||||||||||||||
The loan portfolio held for sale consists of the following loan classes: | ||||||||||||||
As of September 30, 2025, the Company had no loans held for sale. | ||||||||||||||
(in thousands) | September 30, | June 30, | March 31, | December 31, | September 30, | |||||||||
Loans held for sale at the lower of cost or fair value | (audited) | |||||||||||||
Real estate loans | ||||||||||||||
Commercial real estate | ||||||||||||||
Non-owner occupied | $ | — | $ | — | $ | — | $ | — | $ | 111,591 | ||||
Land development and construction loans | — | — | — | — | 35,020 | |||||||||
— | — | — | — | 146,611 | ||||||||||
Single-family residential | — | — | — | — | 87,820 | |||||||||
Owner occupied | — | — | 40,597 | — | 221,774 | |||||||||
— | — | 40,597 | — | 456,205 | ||||||||||
Commercial loans | — | — | — | — | 87,866 | |||||||||
Consumer loans | — | — | — | — | 9,870 | |||||||||
Total loans held for sale at the lower of cost or fair value (1) | — | — | 40,597 | — | 553,941 | |||||||||
Mortgage loans held for sale at fair value | ||||||||||||||
Land development and construction loans | — | 2,056 | 7,475 | 10,768 | 10,608 | |||||||||
Single-family residential | — | 4,017 | 13,253 | 32,143 | 33,243 | |||||||||
Total mortgage loans held for sale at fair value (2) | — | 6,073 | 20,728 | 42,911 | 43,851 | |||||||||
Total loans held for sale | $ | — | $ | 6,073 | $ | 61,325 | $ | 42,911 | $ | 597,792 | ||||
__________________ | ||
(1) | As of September 30, 2024, includes loans transferred from the held for investment to the held for sale category in the third quarter of 2024, as a result of the Houston Transaction. In the fourth quarter of 2024, the Company completed the Houston Transaction. | |
(2) | In prior periods, loans held for sale were in connection with Amerant Mortgage’s ongoing business. | |
Non-Performing Assets | ||||||||||||||
This table shows a summary of our non-performing assets by loan class, which includes non-performing loans, other real estate owned, or OREO, and other repossessed assets at the dates presented. Non-performing loans consist of (i) nonaccrual loans, and (ii) accruing loans 90 days or more contractually past due as to interest or principal. | ||||||||||||||
(in thousands) | September 30, | June 30, | March 31, | December 31, | September 30, | |||||||||
Non-Accrual Loans | (audited) | |||||||||||||
Real Estate Loans | ||||||||||||||
Commercial real estate (CRE) | ||||||||||||||
Non-owner occupied | $ | 4,374 | $ | 1,022 | $ | — | $ | — | $ | 1,916 | ||||
Multi-family residential | 7,018 | — | — | — | — | |||||||||
Land development and construction loans | 19,577 | — | — | 4,119 | — | |||||||||
30,969 | 1,022 | — | 4,119 | 1,916 | ||||||||||
Single-family residential | 8,838 | 7,421 | 15,048 | 8,140 | 13,452 | |||||||||
Owner occupied | 15,287 | 21,027 | 22,249 | 23,191 | 29,240 | |||||||||
55,094 | 29,470 | 37,297 | 35,450 | 44,608 | ||||||||||
Commercial loans | 67,081 | 51,157 | 84,907 | 64,572 | 68,654 | |||||||||
Consumer loans and overdrafts | 725 | 666 | — | — | — | |||||||||
Total Non-Accrual Loans | $ | 122,900 | $ | 81,293 | $ | 122,204 | $ | 100,022 | $ | 113,262 | ||||
Past Due Accruing Loans | ||||||||||||||
Real Estate Loans | ||||||||||||||
Single-family residential | — | — | 886 | 1,201 | 1,129 | |||||||||
Owner occupied | — | — | — | 837 | — | |||||||||
Commercial | 1,392 | 1,192 | 122 | 2,033 | 104 | |||||||||
Consumer loans and overdrafts | — | — | 7 | 8 | 434 | |||||||||
Total Past Due Accruing Loans (1) | $ | 1,392 | $ | 1,192 | $ | 1,015 | $ | 4,079 | $ | 1,667 | ||||
Total Non-Performing Loans | 124,292 | 82,485 | 123,219 | 104,101 | 114,929 | |||||||||
Other Real Estate Owned | 15,606 | 15,389 | 17,541 | 18,074 | 14,509 | |||||||||
Total Non-Performing Assets | $ | 139,898 | $ | 97,874 | $ | 140,760 | $ | 122,175 | $ | 129,438 | ||||
__________________ | ||
(1) | Loans past due 90 days or more but still accruing. | |
Loans by Credit Quality Indicators | ||||||||||||||||||||||||||
This table shows the Company’s loans by credit quality indicators. The Company has not purchased credit-deteriorated loans. | ||||||||||||||||||||||||||
September 30, 2025 | June 30, 2025 | September 30, 2024 | ||||||||||||||||||||||||
(in thousands) | Special Mention | Substandard | Doubtful | Total (1) | Special Mention | Substandard | Doubtful | Total (1) | Special Mention | Substandard | Doubtful | Total (1) | ||||||||||||||
Real Estate Loans | ||||||||||||||||||||||||||
Commercial Real Estate (CRE) | ||||||||||||||||||||||||||
Non-owner occupied | $ | 53,284 | $ | 42,406 | $ | — | $ | 95,690 | $ | 44,084 | $ | 55,382 | $ | — | $ | 99,466 | $ | 34,374 | $ | 1,916 | $ | — | $ | 36,290 | ||
Multi-family residential | — | 29,430 | — | 29,430 | — | 8,284 | — | 8,284 | — | — | — | — | ||||||||||||||
Land development and construction loans | 3,959 | 19,577 | — | 23,536 | 26,574 | — | — | 26,574 | — | — | — | — | ||||||||||||||
57,243 | 91,413 | — | 148,656 | 70,658 | 63,666 | — | 134,324 | 34,374 | 1,916 | — | 36,290 | |||||||||||||||
Single-family residential | 738 | 8,717 | — | 9,455 | — | 7,297 | — | 7,297 | — | 13,544 | — | 13,544 | ||||||||||||||
Owner occupied | 45,365 | 35,085 | — | 80,450 | 21,076 | 61,590 | — | 82,666 | 29,603 | 29,310 | — | 58,913 | ||||||||||||||
103,346 | 135,215 | — | 238,561 | 91,734 | 132,553 | — | 224,287 | 63,977 | 44,770 | — | 108,747 | |||||||||||||||
Commercial loans | 120,997 | 105,905 | — | 226,902 | 41,025 | 82,213 | — | 123,238 | 12,442 | 69,429 | — | 81,871 | ||||||||||||||
Consumer loans and overdrafts | — | 725 | — | 725 | — | 666 | — | 666 | — | — | — | — | ||||||||||||||
Total | $ | 224,343 | $ | 241,845 | $ | — | $ | 466,188 | $ | 132,759 | $ | 215,432 | $ | — | $ | 348,191 | $ | 76,419 | $ | 114,199 | $ | — | $ | 190,618 | ||
__________________ | ||
(1) | There were no loans categorized as "loss" as of the dates presented. | |
Exhibit 8 - Deposits by Country of Domicile | ||||||||||||||
This table shows the Company’s deposits by country of domicile of the depositor as of the dates presented. | ||||||||||||||
(in thousands) | September 30, | June 30, | March 31, | December 31, | September 30, | |||||||||
(audited) | ||||||||||||||
Domestic | $ | 5,732,799 | $ | 5,707,272 | $ | 5,592,575 | $ | 5,278,289 | $ | 5,553,336 | ||||
Foreign: | ||||||||||||||
Venezuela | 1,881,871 | 1,897,631 | 1,862,614 | 1,889,331 | 1,887,282 | |||||||||
Others | 686,299 | 701,641 | 699,789 | 686,975 | 670,326 | |||||||||
Total foreign | 2,568,170 | 2,599,272 | 2,562,403 | 2,576,306 | 2,557,608 | |||||||||
Total deposits | $ | 8,300,969 | $ | 8,306,544 | $ | 8,154,978 | $ | 7,854,595 | $ | 8,110,944 | ||||
Glossary of Terms and Definitions
Total gross loans: include loans held for investment net of unamortized deferred loan origination fees and costs, as well as loans held for sale.
Core deposits: consist of total deposits excluding all time deposits.
Assets under management and custody: consists of assets held for clients in an agency or fiduciary capacity which are not assets of the Company and therefore are not included in the consolidated financial statements.
Net interest margin, or NIM: defined as net interest income, or NII, divided by average interest-earning assets, which are loans, securities, deposits with banks and other financial assets which yield interest or similar income.
ROA and Core ROA are calculated based upon the average daily balance of total assets.
ROE and Core ROE are calculated based upon the average daily balance of stockholders’ equity.
Total revenue is the result of net interest income before provision for credit losses plus noninterest income.
Total capital ratio: total stockholders’ equity divided by total risk-weighted assets, calculated according to the standardized regulatory capital ratio calculations.
Tier 1 capital ratio: Tier 1 capital divided by total risk-weighted assets. Tier 1 capital is composed of Common Equity Tier 1 (CET1) capital plus outstanding qualifying trust preferred securities of $62.3 million at each of all the dates presented.
Tier 1 leverage ratio: Tier 1 capital divided by quarter to date average assets.
Common equity tier 1 capital ratio, CET1: Tier 1 capital divided by total risk-weighted assets.
Tangible common equity ratio: calculated as the ratio of common equity less goodwill and other intangibles divided by total assets less goodwill and other intangible assets. Other intangible assets primarily consist of naming rights and mortgage servicing rights and are included in other assets in the Company’s consolidated balance sheets.
Loans to Deposits ratio: calculated as the ratio of total loans gross divided by total deposits.
Non-performing assets include all accruing loans past due by 90 days or more, all nonaccrual loans and other real estate owned ("OREO") properties acquired through or in lieu of foreclosure, and other repossessed assets.
Non-performing loans include all accruing loans past due by 90 days or more and all nonaccrual loans
Ratio for net charge-offs/average total loans held for investments: calculated based upon the average daily balance of outstanding loan principal balance net of unamortized deferred loan origination fees and costs, excluding the allowance for credit losses.
Other operating expenses: total noninterest expense less salary and employee benefits.
Efficiency ratio: total noninterest expense divided by the sum of noninterest income and NII.
Core ROA, core ROE and core efficiency ratio exclude the effect of non-routine items, described in Exhibit 2 - Non-GAAP Financial Measures Reconciliation.
The terms of the FHLB advance agreements require the Bank to maintain certain investment securities or loans as collateral for these advances.
Cost of total deposits: calculated based upon the average balance of total noninterest bearing and interest bearing deposits, which includes time deposits.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251028986948/en/
Contacts
Investors
Laura Rossi
InvestorRelations@amerantbank.com
(305) 460-8728
Media
Alexis Dominguez
MediaRelations@amerantbank.com
(305) 441-8412